Want­ed: More phar­ma field med­ical teams, as study finds they can amp drug launch sales

The first six months of a drug launch are crit­i­cal to its suc­cess. But phar­ma mar­keters can boost its chances with the ad­di­tion of med­ical sci­ence li­aisons (MSLs) ear­ly in the process, ac­cord­ing to new re­search from Vee­va Sys­tems.

The soft­ware and con­sult­ing com­pa­ny com­pared the suc­cess of a drug when key opin­ion lead­ers (KOLs) in health­care or­ga­ni­za­tions were briefed by phar­ma com­pa­nies’ med­ical field teams ver­sus when they were not. The re­sult was a 150% in­crease in pre­scrip­tions writ­ten across the sys­tem when the MSLs talked to the key lead­ers, who in turn spread the word oth­er HCPs, said Dan Riz­zo, Vee­va’s glob­al head of busi­ness con­sult­ing.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER